HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy. (Q55071600)
Jump to navigation
Jump to search
scientific article published on 4 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy. |
scientific article published on 4 September 2014 |
Statements
HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy. (English)
1 reference
Kyoung-Mee Kim
1 reference
Sang Yun Ha
1 reference
Jeeyun Lee
1 reference
Jiryeon Jang
1 reference
Jung Yong Hong
1 reference
In-Gu Do
1 reference
Se Hoon Park
1 reference
Joon Oh Park
1 reference
Min-Gew Choi
1 reference
Tae Sung Sohn
1 reference
Jae Moon Bae
1 reference
Sung Kim
1 reference
Minji Kim
1 reference
Seonwoo Kim
1 reference
Cheol Keun Park
1 reference
Won Ki Kang
1 reference
4 September 2014
1 reference
136
1 reference
7
1 reference
1629-1635
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference